Little is known about patients' long-term compliance with osteoporosis medications. In a US retrospective cohort study, Solomon et al. assessed the level and determinants of compliance with drugs ...

Osteoporosis medications assessed by the study investigators included several bisphosphonates (for example, alendronate, clodronate and etidronate); raloxifene; strontium ranelate; and parathyroid ...

Information was obtained from the MEPS from the years 1999 to 2005 for all respondents ages 50 years and older who self-reported as having osteoporosis. In the examination of trends in medication ...

[28,29] There were no trends noted in our findings between the decision to take OP medication and age, gender or fracture location. At the time of the interview, 14 patients were taking a ...

Within clearly outlined chapters, "Impact of osteoporosis and osteoporosis medications on fracture healing. A narrative review" examines the biology of fracture healing, clinical and radiological ...

The Holy Grail for the NHS is finding cost-effective ways to help patients with serious health conditions. Chance would be a fine thing, you might think, given the many difficulties facing the ...

@2024 - All Right Reserved.

"There are really good anti-osteoporosis medications which are available to keep bones stronger for longer," reassured Mr Jones. "It's never too early to start thinking about your bone health ...

No matter which osteoporosis drug your doctor chooses for you, it's helpful to know as much as possible about how the disease has affected you. One way to tell is to ask about your "markers." ...

Patients have told ABC NEWS they're concerned about a lack of informed consent over Australia's most common osteoporosis drug and are sometimes "scared into" taking it. Doctors acknowledge Prolia ...

Cancer and osteoporosis patients to benefit from new drug approvalsOpens in new window ] They said the research, published to coincide with World Osteoporosis Day on Sunday, revealed the scale of ...